News of the studies being pulled comes weeks after the CDC decided it wouldn't publish a report showing last winter's covid ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Combriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
Moderna said today the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results